Gastroenterology
Volume 131, Issue 5 , Pages 1400-1407 , November 2006

High Prevalence of Sessile Serrated Adenomas With BRAF Mutations: A Prospective Study of Patients Undergoing Colonoscopy

  • Kevin J. Spring

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • Corresponding Author InformationAddress requests for reprints to: Kevin J. Spring, Conjoint Gastroenterology Laboratory, Bancroft Centre, PO Royal Brisbane Hospital, Herston, 4029 Australia. fax: (61) 733620108.
    • ,
  • Zhen Zhen Zhao

      Affiliations

    • Department of Pathology, McGill University, Montreal, Quebec, Canada
    • ,
  • Rozemary Karamatic

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Michael D. Walsh

      Affiliations

    • Molecular Epidemiology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Vicki L.J. Whitehall

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Tanya Pike

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Lisa A. Simms

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Joanne Young

      Affiliations

    • Molecular Epidemiology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Michael James

      Affiliations

    • Department of Pathology, McGill University, Montreal, Quebec, Canada
    • ,
  • Grant W. Montgomery

      Affiliations

    • Department of Pathology, McGill University, Montreal, Quebec, Canada
    • ,
  • Mark Appleyard

      Affiliations

    • Department of Gastroenterology and Hepatology, Royal Brisbane and Women’s Hospital Research Foundation, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • David Hewett

      Affiliations

    • Department of Gastroenterology and Hepatology, Royal Brisbane and Women’s Hospital Research Foundation, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Kazutomo Togashi

      Affiliations

    • Division of Endoscopy and Department of Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan
    • ,
  • Jeremy R. Jass

      Affiliations

    • Molecular Epidemiology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia
    • ,
  • Barbara A. Leggett

      Affiliations

    • Conjoint Gastroenterology Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Australia

Received 23 May 2006 ,Accepted 3 August 2006.

References 

  1. Kinzler KW, Vogelstein B. Life (and death) in a malignant tumour. Nature. 1996;379:19–20
  2. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96:8681–8686
  3. Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, Pandeya N, et al. Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res. 2002;62:6011–6014
  4. Jass JR. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol. 2005;2:398–405
  5. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma—prevalence, histological features, and prognosis. J Pathol. 2001;193:286–294
  6. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778–796
  7. Hawkins NJ, Bariol C, Ward RL. The serrated neoplasia pathway. Pathology. 2002;34:548–555
  8. Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?. J Clin Pathol. 1999;52:5–9
  9. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380–391
  10. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40
  11. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol. 2003;162:815–822
  12. O’Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423–434
  13. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293–297
  14. Boughdady IS, Kinsella AR, Haboubi NY, Schofield PF. K-ras gene mutations in adenomas and carcinomas of the colon. Surg Oncol. 1992;1:275–282
  15. Chan TL, Zhao W, Leung SY, Yuen ST. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878–4881
  16. Yang S, Farraye FA, Mack C, Posnik O, O’Brien MJ. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452–1459
  17. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954
  18. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137–1144
  19. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65–81
  20. Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res. 1999;27:e12
  21. James MR, Dumeni T, Stark MS, Duffy DL, Montgomery GW, Martin NG, et al. Rapid screening of 4000 individuals for germline mutations in the BRAF gene. Clin Chem. 2006;52:1675–1678
  22. Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:254–263
  23. Frazier ML, Xi L, Zong J, Viscofsky N, Rashid A, Wu EF, et al. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 2003;63:4805–4808
  24. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65:6063–6069
  25. Rabeneck L, Davila JA, El-Serag HB. Is there a true “shift” to the right colon in the incidence of colorectal cancer?. Am J Gastroenterol. 2003;98:1400–1409
  26. Lazarus R, Junttila OE, Karttunen TJ, Makinen MJ. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol. 2005;123:349–359
  27. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191–2200
  28. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49:819–825
  29. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23:835–842
  30. Paspatis GA, Papanikolaou N, Zois E, Michalodimitrakis E. Prevalence of polyps and diverticulosis of the large bowel in the Cretan population (An autopsy study). Int J Colorectal Dis. 2001;16:257–261
  31. Hurlstone DP, Cross SS, Slater R, Sanders DS, Brown S. Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Gut. 2004;53:376–380
  32. Jarry A, Masson D, Cassagnau E, Parois S, Laboisse C, Denis MG. Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E. Mol Cell Probes. 2004;18:349–352
  33. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 2002;62:6451–6455
  34. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005;166:1069–1075

 Supported by the Royal Brisbane and Women’s Hospital Foundation and by grants from the Queensland Cancer Fund (#145 to K.J.S.) and the National Health and Medical Research Council (#290203 to B.A.L.).

PII: S0016-5085(06)01798-7

doi: 10.1053/j.gastro.2006.08.038

Gastroenterology
Volume 131, Issue 5 , Pages 1400-1407 , November 2006

Article Tools

* Image Usage & Resolution